News Releases

21st Century Biochemicals Marks Its Third Consecutive Year on the Inc. 5000

NEW YORK, Aug. 30 /PRNewswire/ -- 21st Century Biochemicals, Inc. of Marlborough, MA was included on Inc. Magazine's annual ranking of the 5,000 fastest-growing private companies in the country for the third consecutive year.  For 2010, 21st Century Biochemicals was ranked #2626 after being ranked #575 in 2008 and #2116 in 2009. The list is the most comprehensive look at the most important segment of the economy – America's independent-minded entrepreneurs.  Taken as a whole, these companies represent the backbone of the U.S. economy. 

(Logo:  http://photos.prnewswire.com/prnh/20100817/INC5000LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO)

21st Century Biochemicals, Inc., founded in 2003, manufactures custom made biochemicals and provides analytical services for use in pharmaceutical and biomedical research laboratories around the globe.  Their products are used in research laboratories studying among other things Alzheimer's disease, cancer, and heart disease as well as those labs doing basic research.  According to Dr. Jordan B. Fishman, Founder and CEO of 21st Century Biochemicals, "Making the list three times in a row is really a testament to our employees and their skill, hard work and dedication.  We often hear from our customers at how pleased they are with the technical support they receive as well as our customer service and product quality.  I could not be prouder of the group of professionals we have assembled."   Dr. Fishman added: "Our scientific staff, of which over one-third hold advanced degrees including PhD's in Biochemistry, Immunology, Neuroscience and Cell Biology, interact with our customers on a very high scientific level with the focus on problem solving in areas where we have expertise.   Thus, rather than just being a source of finished goods, we can act as an extension of their laboratory when needed."

"The leaders of the companies on this year's Inc. 5000 have figured out how to grow their businesses during the longest recession since the Great Depression," said Inc. president Bob LaPointe. "The 2010 Inc. 5000 showcases a particularly hardy group of entrepreneurs."  

"There is no doubt that the current economic climate has presented us and really all companies with a much tougher playing field," according to Dr. Fishman. "We have focused on customer service, product quality, and employee retention as the cornerstones that will allow us to get through until the economy picks up steam.  Thankfully our team has stepped up to the plate during this time and has played a major role in our continuing growth.  Our scientific expertise and ability to utilize our knowledge and skills to help our customers achieve their goals has resulted in growing referrals, published papers citing our work, and co-authorships on several scientific papers."

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found on http://www.inc.com/5000.

http://www.21stcenturybio.com

SOURCE 21st Century Biochemicals, Inc.

For further information: Jordan B. Fishman, PhD, President and Chief Scientific Officer of 21st Century Biochemicals, Inc., Info@21stcenturybio.com